Pulmonary functional outcome at one year of age in infants treated with natural porcine surfactant at birth.

This prospective study was designed to assess pulmonary function (functional residual capacity, FRC; dynamic lung compliance, CLdyn; and total pulmonary resistance, RL) at 1 year of corrected age in infants with neonatal respiratory distress syndrome treated with natural porcine surfactant (Curosurf) (n = 13), as compared to nontreated control infants (n = 9). Values from 21 healthy infants of similar age served as reference. We found similar pulmonary dysfunction (decreased CLdyn, elevated RL) in both patient groups. These results suggest that surfactant replacement therapy does not affect pulmonary function at 1 year of age in infants who survive respiratory distress syndrome.
AuthorsH Walti, M Boulé, G Moriette, J P Relier
JournalBiology of the neonate (Biol Neonate) Vol. 61 Suppl 1 Pg. 48-53 ( 1992) ISSN: 0006-3126 [Print] SWITZERLAND
PMID1391266 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Biological Products
  • Phospholipids
  • Pulmonary Surfactants
  • poractant alfa
  • Airway Resistance (drug effects)
  • Biological Products
  • Follow-Up Studies
  • Functional Residual Capacity (drug effects)
  • Humans
  • Infant
  • Infant, Low Birth Weight
  • Infant, Newborn
  • Lung (drug effects)
  • Lung Compliance (drug effects)
  • Phospholipids
  • Prospective Studies
  • Pulmonary Surfactants (pharmacology)
  • Respiratory Distress Syndrome, Newborn (drug therapy, mortality)
  • Respiratory Mechanics (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: